Actionable news
All posts from Actionable news

Salesforce's Underlying Story Is Unchanged, Says Barclays Inc NYSE:CRM, LinkedIn Corporation NYSE:LNKD - Salesforce's Underlying Story Is Unchanged, Says Barclays, inc. CRM 1.07% reported robust quarterly results, with the revenue and EPS ahead of the consensus expectations.

Barclays’ Raimo Lenschow reiterated an Overweight rating on the company with a price target of $89.

Billings Disappoints

Despite the overall robust results, billings and the Q3 guidance were marginally lower than expected.

“The company pointed to some softness in the US towards the end of the second quarter but did not provide much further detail, which will likely keep the shares in check for the time being,” Lenschow mentioned. reported billings growth of about 15 percent year-on-year for Q2, while guiding to billings growth of 12 percent for Q3.

“The company mentioned some deal weakness at the end of the quarter as a main factor but we wonder how much the strong performance in Q1 also played a role here as the company had an incentive to deliver strong Q1 results given its all share offer for LinkedIn Corp LNKD 0.04%,” the analyst stated.

Margins Improve

On the other hand, margins improved slightly in Q2, despite FX and M&A headwinds.

Lenschow believes management is committed to delivering revenue growth while also continuing to improve margins.

Story Unchanged

“Salesforce's comments about weakness at the end of the quarter will increase the nervousness for the whole space. However, we believe CRM is a premium asset and hence investors should look at the name,” the analyst went on to say.

Lenschow believes has scale as well as several growth options, which were likely to drive relative outperformance, even in a slower spending environment.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Sep 2016WunderlichMaintainsBuy
Sep 2016BarclaysMaintainsOverweight
Sep 2016Morgan StanleyMaintainsOverweight

© 2016 Benzinga does not provide investment advice. All rights reserved.